Evaluation of a novel virtual care platform for remote monitoring of LVAD patients

Shreyans K. Patel, Anne Luke, Andrew Schutt, Thiru Chinnadurai, Aashna Pandya, Omar Saeed, Daniel Goldstein, Ulrich Jorde, Snehal R. Patel

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to evaluate a novel virtual care platform created for use in Left Ventricular Assist Device (LVAD) patients. The platform included a daily log of LVAD parameters and medication adherence, two-way messaging with providers, and educational resources. To test the feasibility of this application, we recruited 25 patients between 2017 and 2019 and followed them for 6 months post discharge. Feedback concerning the platform was very positive with an average score of 4.5 ± 0.6 (out of 5) on usability and/or satisfaction and 8.1 ± 1.8 (out of 10) on likelihood to recommend the platform. In addition, our platform was well utilized with median (IQR) engagement rates of 87 (53,100)% at 30 days and 73 (49,95)% overall. We found that patients using the platform attended significantly less outpatient visits at the 6 month mark, however there was no difference in 30-day readmission rates compared to the overall LVAD cohort.

Original languageEnglish (US)
Pages (from-to)558-562
Number of pages5
JournalJournal of Heart and Lung Transplantation
Volume41
Issue number5
DOIs
StatePublished - May 2022

Keywords

  • LVAD
  • patient satisfaction
  • readmissions
  • telehealth
  • virtual care

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine
  • Transplantation

Fingerprint

Dive into the research topics of 'Evaluation of a novel virtual care platform for remote monitoring of LVAD patients'. Together they form a unique fingerprint.

Cite this